ReWalk Robotics Files 8-K on Financials
Ticker: LFWD · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1607962
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
ReWalk Robotics dropped an 8-K on August 15th detailing their financial condition and operations.
AI Summary
ReWalk Robotics Ltd. filed an 8-K on August 15, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's performance. The company, formerly known as Argo Medical Technologies Ltd., is incorporated in Israel and trades on NASDAQ.
Why It Matters
This 8-K filing provides investors with crucial updates on ReWalk Robotics' financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial or operational news that may impact a company's stock price.
Key Players & Entities
- ReWalk Robotics Ltd. (company) — Registrant
- Argo Medical Technologies Ltd. (company) — Former company name
- August 15, 2024 (date) — Date of earliest event reported
- NASDAQ (company) — Stock exchange
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated August 15, 2024.
What is ReWalk Robotics Ltd.'s former company name?
ReWalk Robotics Ltd.'s former company name was Argo Medical Technologies Ltd.
Where is ReWalk Robotics Ltd. incorporated?
ReWalk Robotics Ltd. is incorporated in Israel.
What is the principal executive office address for ReWalk Robotics Ltd.?
The principal executive offices are located at 200 Donald Lynch Blvd., Marlborough, MA 01752.
Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-08-15 08:15:14
Filing Documents
- zk2431866.htm (8-K) — 38KB
- exhibit_99-1.htm (EX-99.1) — 574KB
- image00005.jpg (GRAPHIC) — 4KB
- 0001178913-24-002647.txt ( ) — 777KB
- rwlk-20240815.xsd (EX-101.SCH) — 4KB
- rwlk-20240815_lab.xml (EX-101.LAB) — 21KB
- rwlk-20240815_pre.xml (EX-101.PRE) — 16KB
- zk2431866_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 15, 2024, ReWalk Robotics Ltd. (the "Company," "we" or "us") issued a press release announcing its financial results for the second quarter ended June 30, 2024. A copy of the press release is being furnished herewith as Exhibit 99.1. As set forth in the press release, the Company will host a conference call to discuss its financial results for the second quarter ended June 30, 2024, on August 15, 2024 at 8:30 a.m. E.D.T. The archived webcast will be available at https://edge.media-server.com/mmc/p/i8mtrha9 and/or through the Company's website at www.golifeward.com under the "Investors" section for 30 days after the completion of the call. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "1934 Act"), nor shall it be deemed "incorporated by reference" into any filing under the Securities Act of 1933, as amended, or the 1934 Act, except as may be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release dated August 15, 2024 of ReWalk Robotics Ltd., announcing financial results for the second quarter ended June 30, 2024.* 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Furnished herewith
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ReWalk Robotics Ltd. Dated: August 15, 2024 By: /s/ Michael Lawless Name: Michael Lawless Title: Chief Financial Officer